@article{yu2008phase,
  title={A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal},
  author={Yu, Elmer and Miotto, Karen and Akerele, Evaristo and Montgomery, Ann and Elkashef, Ahmed and Walsh, Robert and Montoya, Ivan and Fischman, Marian W and Collins, Joseph and McSherry, Frances and others},
  journal={Drug and alcohol dependence},
  volume={97},
  number={1-2},
  pages={158--168},
  year={2008},
  publisher={Elsevier}
}

@article{pergolizzi2019role,
  title={The role of lofexidine in management of opioid withdrawal},
  author={Pergolizzi Jr, Joseph V and Annabi, Hani and Gharibo, Christopher and LeQuang, Jo Ann},
  journal={Pain and therapy},
  volume={8},
  number={1},
  pages={67--78},
  year={2019},
  publisher={Springer}
}

@article{lopez1984comparative,
  title={Comparative efficacy and safety of lofexidine and clonidine in mild to moderately severe systemic hypertension},
  author={Lopez, Larry M and Mehta, Jawahar L},
  journal={The American Journal of Cardiology},
  volume={53},
  number={6},
  pages={787--790},
  year={1984},
  publisher={Elsevier}
}